BR112021024423A2 - Composição canabinoide termogelificante e método para fabricação e uso da mesma - Google Patents

Composição canabinoide termogelificante e método para fabricação e uso da mesma

Info

Publication number
BR112021024423A2
BR112021024423A2 BR112021024423A BR112021024423A BR112021024423A2 BR 112021024423 A2 BR112021024423 A2 BR 112021024423A2 BR 112021024423 A BR112021024423 A BR 112021024423A BR 112021024423 A BR112021024423 A BR 112021024423A BR 112021024423 A2 BR112021024423 A2 BR 112021024423A2
Authority
BR
Brazil
Prior art keywords
cannabinoid
composition
thermogelling
manufacture
cannabinoid composition
Prior art date
Application number
BR112021024423A
Other languages
English (en)
Inventor
Francois Chouinard
George Elvira
Jamie Savard
Original Assignee
Hexo Operations Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexo Operations Inc filed Critical Hexo Operations Inc
Publication of BR112021024423A2 publication Critical patent/BR112021024423A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing six-membered aromatic rings and other rings, with unsaturation outside the aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

composição canabinoide termogelificante e método para fabricação e uso da mesma. a presente revelação se refere a uma composição canabinoide que tem taxas de absorção intensificadas ou concentrações mais altas do canabinoide administrado na circulação sistêmica, em que a composição compreende pelo menos um canabinoide e um modificador de viscosidade presente em uma quantidade eficaz para mudar a composição de um líquido a cerca da temperatura ambiente para um gel ao aumentar para cerca da temperatura corporal. a revelação também se refere a métodos para uso das composições e produtos canabinoides que compreendem tais composições.
BR112021024423A 2019-06-06 2020-06-05 Composição canabinoide termogelificante e método para fabricação e uso da mesma BR112021024423A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962858112P 2019-06-06 2019-06-06
PCT/CA2020/050780 WO2020243844A1 (en) 2019-06-06 2020-06-05 Thermogelling cannabinoid composition and method of manufacture and use thereof

Publications (1)

Publication Number Publication Date
BR112021024423A2 true BR112021024423A2 (pt) 2022-01-18

Family

ID=73652381

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021024423A BR112021024423A2 (pt) 2019-06-06 2020-06-05 Composição canabinoide termogelificante e método para fabricação e uso da mesma

Country Status (11)

Country Link
US (1) US20220313597A1 (pt)
EP (1) EP3980043A4 (pt)
JP (1) JP2022535438A (pt)
KR (1) KR20220017943A (pt)
CN (1) CN114269365A (pt)
AU (1) AU2020287079A1 (pt)
BR (1) BR112021024423A2 (pt)
CA (1) CA3142538A1 (pt)
IL (1) IL288646A (pt)
MX (1) MX2021014934A (pt)
WO (1) WO2020243844A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2021330383A1 (en) * 2020-08-31 2023-04-06 PreveCeutical Medical Inc. Cannabinoid formulations and methods of use
US20220117278A1 (en) * 2020-10-21 2022-04-21 Corn Products Development, Inc. Cannabinoid emulsions
AU2021384063A1 (en) * 2020-11-20 2023-07-06 PreveCeutical Medical Inc. Sol-gel cannabinoid formulation and antiviral use
PL438500A1 (pl) * 2021-07-16 2023-01-23 Uniwersytet Medyczny Im.Piastów Śląskich We Wrocławiu Kompozycja farmaceutyczna na bazie oleju roślinnego i trójblokowego kopolimeru, kompozycja wielofazowa w postaci emulżelu oraz sposób wytwarzania kompozycji
IT202100023063A1 (it) * 2021-09-07 2023-03-07 Herbal Neurocare S R L Composizione a base di cannabidiolo per il trattamento dei disturbi neuropsichici, infiammatori e da dolore, nell’uomo e negli animali

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9107815B2 (en) * 2008-02-22 2015-08-18 Allergan, Inc. Sustained release poloxamer containing pharmaceutical compositions
WO2011049958A2 (en) * 2009-10-21 2011-04-28 Otonomy, Inc. Modulation of gel temperature of poloxamer-containing formulations
WO2017072774A1 (en) * 2015-10-29 2017-05-04 Solubest Ltd Pharmaceutical compositions for transmucosal delivery
US20200289458A1 (en) * 2017-09-22 2020-09-17 Inmed Pharmaceuticals Inc. Topical formulations of cannabinoids and use thereof in the treatment of pain

Also Published As

Publication number Publication date
KR20220017943A (ko) 2022-02-14
IL288646A (en) 2022-02-01
JP2022535438A (ja) 2022-08-08
CN114269365A (zh) 2022-04-01
CA3142538A1 (en) 2020-12-10
EP3980043A4 (en) 2023-07-19
EP3980043A1 (en) 2022-04-13
AU2020287079A1 (en) 2022-01-06
MX2021014934A (es) 2022-03-17
WO2020243844A1 (en) 2020-12-10
US20220313597A1 (en) 2022-10-06

Similar Documents

Publication Publication Date Title
BR112021024423A2 (pt) Composição canabinoide termogelificante e método para fabricação e uso da mesma
BR112020022664A8 (pt) Composições refrigerante, método para a aquecer ou resfriar e recipiente
BR112017014049A2 (pt) método para reduzir a perda de circulação em uma formação subterrânea, fluido de tratamento e sistema para obstrução de uma zona de perda de circulação
BR112015032813A2 (pt) método de tratamento de uma zona de tratamento de um poço, e, composição
BR132022001907E2 (pt) Partículas de nanoalume contendo um agente de dimensionamento
BR112016027867A2 (pt) composições de fibra e de carboidrato, produto alimentício, métodos para produzir uma composição de fibra, de carboidrato, para reduzir o índice glicêmico e para inibir a elevação do nível de açúcar, composição cosmética, uso da composição de fibra e composição
BR112019003770A2 (pt) formulação líquida que contém toxina botulínica e agente de estabilização, e método de preparação para a mesma
BR112016013684A2 (pt) Solução aquosa ou hidrocoloide, método para aumentar a viscosidade de uma composição e método para o tratamento de um material
BR112015030339A8 (pt) método para tratamento de uma formação subterrânea
BR112015017955A2 (pt) barras de progresso de múltiplos níveis, método e aparelho de controle do progresso
BR112018077481A2 (pt) película de polipropileno biaxialmente orientada de mono ou multicamadas, processo para produção de uma película de polipropileno biaxialmente orientada de mono ou multicamadas, usos de pelo menos um carbonato de cálcio natural e de uma película de polipropileno biaxialmente orientada de mono ou multicamadas, e, artigo.
BR112016002233A2 (pt) composições de adoçante
BR112015018715A2 (pt) redução microbiana em produto nutricional usando um processo de extrusão
BR112012005659A2 (pt) composição lubrificante de trator de fazenda com boa tolerância á água.
BR112016013916A2 (pt) Composição que compreende um veículo líquido e lignina ou derivados da lignina solubilizados no dito carreador líquido, método para a produção de combustíveis através do tratamento da composição, combustível ou lubrificante e método para a preparação da composição
BR112015017246A2 (pt) formulação farmacêutica que compreende um corticosteroide insolúvel e um corticosteroide solúvel
BR112015023728A2 (pt) compósito, processo para preparação de um compósito, produto de consumo, uso de um compósito, e, método para preparação de um produto
BR112017022971A2 (pt) aperfeiçoamentos em ou com relação a compostos orgânicos
BR112018015223A2 (pt) ?métodos para produção de um látex de polímero, de uma composição de látex e de um artigo moldado por imersão?
BR112014032711A2 (pt) composição redutora compreendendo pelo menos um agente redutor contendo enxofre, pelo menos uma substância graxa, pelo menos um tensioativo catiônico e pelo menos um tensioativo não iônico oxietilenado
BR112019001894A2 (pt) kits para preparar uma composição fluida hemostática e método para preparar uma composição fluida hemostática com o kit
BR112015029779A8 (pt) processo para a produção de uma quitosana alcalina com baixo teor de endotoxinas, quitina ou um derivado das mesmas; processo para a produção de uma quitosana neutra com baixo teor de endotoxinas, um sal de quitosana ou um derivado de quitosana; quitosana alcalina com baixo teor de endotoxinas, quitina, um derivado de quitosana ou um derivado de quitina; quitosana alcalina, quitina, um derivado de quitosana ou um derivado de quitina, ou uma quitosana neutra, um sal de quitosana ou um derivado de quitosana; e curativo hemostático para ferida
BRPI0408827A (pt) composições oftálmicas preservadas
BR112019021452A8 (pt) Composição aglutinante, artigo, e método para fabricar um artigo
BR112018001295A2 (pt) ?uso combinado de pelo menos um derivado de molibdênio e pelo menos um derivado de boro e uso de uma combinação de pelo menos um derivado de molibdênio e pelo menos um derivado de boro?

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]